Birth Defect Report Trimmed By Judge In Zofran MDL

By Nadia Dreid (October 23, 2019, 9:33 PM EDT) -- GlaxoSmithKline convinced a Massachusetts federal judge to slice off part of an expert report by a doctor who testified anti-nausea drug Zofran can cause birth defects when taken by pregnant women.

U.S. District Judge F. Dennis Saylor IV on Wednesday granted the pharmaceutical company's bid to remove a supplement to the expert report, which added information about birth defects gleaned from then-recently released studies, ruling it was added too late in the game.

"[P]laintiffs do not have a compelling need for the late evidence," Judge Saylor wrote in his 11-page order. "Dr. Danielsson has already affirmed in his November 2018 supplemental...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!